Schedule 13G ownership disclosure
DICERNA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 253031108
Event date: 2017-12-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,836,547
- Percent of class
- 9.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-18-000004
- Form type
- SC 13G
- Filer
- Dicerna Pharmaceuticals Inc
- CIK
- CIK 1399529
- Filed
- Jan 03, 2018
- Reporting period
- Dec 20, 2017
- Description
- Schedule 13G beneficial ownership